SuperworthAbCellera Biologics market cap ABCL
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $3.6B
- Highest close in our data
- $8.7B
- May 2021
AbCellera Biologics is worth $3.6B at the close on Oct 23, 2026, at $11.82 a share.
That is up 114% over the last year and down 17% over five years.
Its highest close in our data was $8.7B in May 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3.6B | $910M | $4.2B | +238% |
| 2025 | $1.1B | $588M | $1.8B | +21% |
| 2024 | $883.1M | $704.3M | $1.7B | −47% |
| 2023 | $1.7B | $1.1B | $3.2B | −43% |
| 2022 | $2.9B | $2.1B | $4.1B | −28% |
| 2021 | $4B | $3.9B | $8.7B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest AbCellera Biologics' size, closest first, today.
| Company | Market cap |
|---|---|
| ABCLAbCellera Biologics | $3.6B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| INDVIndivior Pharmaceuticals | $4.1B |
| NRIXNurix Therapeutics | $2.8B |
| PBHPrestige Consumer Healthcare | $2.3B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| HRMYHarmony Biosciences | $2.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| Peer median | $3.9B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on AbCellera Biologics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.